• Skip to content
  • Skip to footer
  • Accessibility options
University of Brighton
  • About us
  • Business and
    employers
  • Alumni and
    supporters
  • For
    students
  • For
    staff
  • Accessibility
    options
Open menu
Home
Home
  • Close
  • Study
    • Courses and subjects
    • Find a course
    • A-Z course list
    • Explore our subjects
    • Academic departments
    • Visiting the university
    • Explore online
    • Online events
    • Virtual tours
    • Chat to our students and staff
    • Open days
    • Applicant days
    • Order a prospectus
    • Ask a question
    • Studying here
    • Clearing 2021
    • Accommodation and locations
    • Applying
    • Undergraduate
    • Postgraduate
    • Transferring from another university
    • The Student Contract
    • International students
    • Fees and finance
    • Advice and help
    • Advice for students
    • Advice for parents and carers
    • Advice for schools and teachers
    • Managing your application
    • Undergraduate
    • Postgraduate
  • Research and enterprise
    • Research and enterprise
    • Research and enterprise organisation
    • Brighton Futures – our themes
    • Centres of Research and Enterprise Excellence (COREs)
    • Research and Enterprise Groups (REGs)
    • Our research database
    • Information for business
    • Community University Partnership Programme (CUPP)
    • Postgraduate research degrees
    • PhD research disciplines and programmes
    • PhD funding opportunities and studentships
    • How to apply for your PhD
    • Research environment
    • Investing in research careers
    • Strategic plan
    • Research concordat
    • News, events, publications and films
    • Research and enterprise news
    • Research and enterprise public events
    • Inaugural lectures
    • Research publications and films
    • Academic staff search
  • About us
  • Business and employers
  • Alumni, supporters and giving
  • Current students
  • Staff
  • Accessibility
Search our site
Image of checkland building falmer campus
About us
  • Your university
  • Governance and structure
  • Working with us
  • Statistics and legal
  • News and events
  • Contact us
  • News and events
    • News and events
    • Coronavirus
    • News
    • Events
    • Livestream
    • MA Shows
    • Open lectures
    • Term dates
  • News
    • News
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013

First trial of personalised care for children with asthma suggests benefits

Selecting treatments according to genetic differences could help children with asthma, according to research by Brighton and Sussex Medical School (BSMS).

8 September 2020

The trial compares patients treated according to existing guidelines with those treated by ‘personalised medicine’ and is the first of its kind in children and teenagers.

Researchers say that more work is needed, but their findings hint that children’s asthma symptoms could be better controlled with personalised treatments.

The study was presented at the virtual European Respiratory Society International Congress, by Dr Tom Ruffles, honorary consultant in paediatric respiratory medicine, who worked with the study team led by Professor Somnath Mukhopadhyay, Chair in Paediatrics. Both are based at the Royal Alexandra Children’s Hospital, and BSMS, UK. The trial was conducted and managed by the Tayside Clinical Trials Unit at the University of Dundee, UK.

Asthma inhaler

Asthma inhaler

Dr Ruffles told the conference: “Asthma is a common condition in children that causes coughing, wheezing and difficulty breathing. In the UK, for example, asthma affects one in 11 children and every 18 minutes a child is admitted to hospital because of their asthma.

“We have a number of medicines that are generally effective in treating children with asthma, but they don’t work equally well for all children. We think that genetic differences could have an effect on whether these medicines work, and that’s what we wanted to examine in this study.”

The research involved 241 young people aged between 12 and 18 who were all being treated for asthma by their GPs. The children were randomly assigned either to receive treatment according to existing guidelines, or to receive treatment according to particular genetic differences (their genotype), an approach known as personalised medicine.

Treatment according to genotype meant the children were asked to give a sample of cells scraped from the inside of their cheeks. These samples were tested for different versions of a particular gene, using a test that costs less than €20.

The researchers were testing for a small difference in the gene that contains instructions for making the beta-2 receptor and they were looking for children who had either with one copy of the altered gene or with two copies of the altered gene. The beta-2 receptor is the molecule that is targeted by asthma treatments. Therefore, researchers believe that different versions of the gene for making this receptor can influence how well treatments work.

Previous research suggests that the majority of children with asthma will benefit from standard treatment with an asthma preventer called salmeterol in addition to their regular steroid inhaler. However, around one in seven children have a small genetic difference that means using this medication could actually result in these children having more asthma symptoms.

In this trial, children in the personalised medicine group who had this genetic difference were treated with an alternative asthma medicine called montelukast.

Researchers followed the children for a year to monitor their quality of life, with a score between one and seven according to how their symptoms were, whether their normal activities were limited by their asthma and how their asthma made them feel.

They compared the average score of the group of children who had their medication decided on the basis of their genetics with the average score of children who were treated according to current practice that does not involve any genetic testing, and found only a small improvement of 0.16 with those who received personalised care.

However, when the researchers looked specifically at the children who were found to have two copies of the altered beta-2 receptor gene, they found a greater benefit, with children experiencing an average 0.42 improvement in their quality of life score. The researchers say this would translate to a noticeably better quality of life for the children with two altered gene copies.

Professor Mukhopadhyay said: “These results are very promising because they show, for the first time, that it could be beneficial to test for certain genetic differences in children with asthma and select medication according to those differences.

“In this study, we saw only a modest effect, but this may be partly because the children’s asthma was generally very well controlled and only a few children experienced any serious symptoms during the 12-month period. Larger trials, with a focus on those with poorer asthma control, may help us determine the true benefit for children of prescribing in this way.”

Professor Chris Brightling, from the University of Leicester, UK, is European Respiratory Society Science Council Chair and was not involved in the research. He said: “This approach of ‘personalised care’ for both children and adults with asthma is an important goal for respiratory research.

“In this study, researchers used genetic information that we know is linked to how well patients respond to some inhaler treatments. They found that making use of this genetic information improved the outcome for children with asthma.”

Back to top
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Contact us

University of Brighton
Mithras House
Lewes Road
Brighton
BN2 4AT

Main switchboard 01273 600900

Course enquiries

Sign up for updates

University contacts

Report a problem with this page

Quick links

  • Courses
  • Open days
  • Order a prospectus
  • Academic departments
  • Academic staff
  • Professional services departments
  • Jobs
  • Privacy and cookie policy
  • Accessibility statement
  • Libraries
  • Term dates
  • Maps
  • Graduation
  • Site information
  • Online shop
  • COVID-19

Information for

  • Current students
  • International students
  • Media/press
  • Careers advisers/teachers
  • Parents/carers
  • Business/employers
  • Alumni/supporters
  • Suppliers
  • Local residents